Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel (opens in a new tab)
Active, not recruitingPhase 2/3
DocetaxelBicalutamideDegarelix
Dr. John Romeo Mansueti, MD
NPI1699776955PAC ID6305001322
- Medicare services, 2024
- 6,192
- Medicare patients, 2024
- 456
- Part D claims, 2024
- 245
- Clinical trials
- 6
- Hospital affiliations
- 4
- Practice address
- 801 Middleford Rd, Seaford, DE 19973
- Practice phone
- Call (302) 629-6611
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Mansueti's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. John Romeo Mansueti is a radiation oncologist in Seaford, Delaware
Dr. Mansueti practices at TidalHealth Nanticoke in Seaford, Delaware, part of TidalHealth Peninsula Regional.
Dr. Mansueti's NPI, 1699776955, was assigned on August 9, 2005. Dr. Mansueti graduated from Uniformed Services UHS Fe Hebert School of Med in 1999. Dr. Mansueti holds Virginia license 0101228433.
NPI and contact details
- NPI
- 1699776955NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6305001322
- NPI enumeration date
- August 9, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (302) 629-6611
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. John Romeo Mansueti practices at TidalHealth Nanticoke in Seaford, Delaware
Dr. Mansueti's primary practice is TidalHealth Nanticoke, at 801 Middleford Rd, Seaford, DE 19973 in Sussex County. The practice phone is (302) 629-6611.
- TidalHealth Nanticoke801 Middleford Rd, Seaford, DE 19973 · Sussex CountyPhone(302) 629-6611
Source: Dmand AI Affiliation Data
Dr. John Romeo Mansueti is affiliated with 6 sites of care and 1 medical group
Dr. Mansueti's primary practice is TidalHealth Nanticoke in Seaford, Delaware, part of TidalHealth Peninsula Regional. Dr. Mansueti is also affiliated with TidalHealth Peninsula Regional. The medical group on file is Associates in Radiation Medicine. Dmand AI also links Dr. Mansueti to 2 more hospitals, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.
TidalHealth Peninsula RegionalAssociates in Radiation Medicine2 hospitalsNames with a free account1 group practice or clinicName with a free account1 therapy and rehab clinicName with a free account
See all 7 affiliations for Dr. MansuetiSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. John Romeo Mansueti's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mansueti practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| TidalHealth Nanticoke | Available with a free account |
| +5 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Mansueti practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across TidalHealth Peninsula Regional and 6.2K+ hospitals, with verified contacts in the same login.
Dr. John Romeo Mansueti is one of 21 radiation oncologists in Delaware
Radiation oncology is Dr. Mansueti's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Mansueti is licensed in Virginia.
Specialties and state licenses
- Radiation oncology, VirginiaPrimary
Radiation oncologists near Dr. Mansueti
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
21radiation oncologists in Delaware
3radiation oncologists in Seaford
3radiation oncologists at TidalHealth NanticokeSources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. John Romeo Mansueti billed Medicare for 6,192 services in 2024
CMS data shows 6,192 Medicare services from Dr. Mansueti across 23 procedure codes in 2024, for 456 Medicare patients. Medicare paid $1,052,631 for them.
Medicare services, 20246,192
Medicare patients456
Paid by Medicare$1.1M
Procedure codes23
Dr. Mansueti's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 2,9122024: 3,42918%
- Other services
- 2023: 1,9622024: 2,20913%
- Office and hospital visits
- 2023: 4982024: 55411%
Where Dr. Mansueti's Medicare services took place, 2024
- In an office6,168100%
- In a facility240%
Dr. Mansueti compared with the Delaware median for radiation oncologists, 2024
- Dr. Mansueti
- Delaware median
- Medicare services
- 6,192vs 3,0892.0 times
- Medicare patients
- 456vs 38319% above
- Part D claims
- 152vs 10446% above
Medians across 20 radiation oncologists in Delaware with Dmand AI profiles that report each measure.
Dr. Mansueti's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mansueti?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mansueti and other radiation oncologists in Delaware.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. John Romeo Mansueti treated 456 Medicare patients in 2024, average age 74
CMS counts 456 Medicare patients who saw Dr. Mansueti in 2024. The largest group is 65 to 74, with 218 patients. 75% of them have cancer, and 75% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mansueti's median patient age at 71, with 30% women.
Medicare patients, 2024456
Average age74
Average risk score1.51
Also on Medicaid7%
Dr. Mansueti's Medicare patients by age, 2024
Dr. Mansueti's Medicare patients by sex, 2024
- Women18240%
- Men27460%
Chronic conditions among Dr. Mansueti's Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis46%
- Ischemic heart disease33%
- Diabetes32%
- Anxiety26%
- Chronic kidney disease25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mansueti's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 71
Patient panel by sex, all payers
- Women30%
- Men70%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. John Romeo Mansueti wrote 245 Medicare Part D claims in 2024
In 2024, Dr. Mansueti wrote 245 Medicare Part D claims for 81 patients. 95% of them were for generic drugs. CMS names the drug for 152 of them, across 4 drugs with 11 or more claims each, at $2,509 in total drug cost. In 2023, CMS named 89 claims across 2 drugs.
Part D claims, 2024245
Drugs named by CMS4
Total drug cost$2,509
Part D patients81
Dr. Mansueti's Part D claims by kind of drug, 2024
- Generic232 claims95%
- Brand-name13 claims5%
Dr. Mansueti's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Mansueti's Part D claims, 2024
- Opioids23%57 of 245 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 892024: 15271%
Drugs named by CMS: 4 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. John Romeo Mansueti scored 0 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Mansueti for performance year 2024, reported individually. Dr. Mansueti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Mansueti's MIPS scores, performance year 2024
- 0of 100Final score
- 0of 100Quality
- 0of 100Promoting Interoperability
- 0of 100Improvement Activities
- 0of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find radiation oncologists like Dr. Mansueti by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. John Romeo Mansueti has worked on 6 clinical trials
Dmand AI links Dr. Mansueti to 6 clinical trials, 3 of them phase 3 studies. 6 are still active or recruiting. Conditions studied include Carcinoma, Lobular, Carcinoma, Non-Small-Cell Lung and Prostatic Neoplasms. NRG Oncology sponsors the most, 4.
Clinical trials with Dr. Mansueti by phase
- NonePhase 1: no trials
- 1Phase 2: 1 trial
- 2Phase 2/3: 2 trials
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Mansueti's trials
- Carcinoma, Lobular
- Carcinoma, Non-Small-Cell Lung
- Prostatic Neoplasms
- Carcinoma, Bronchogenic
- Carcinoma, Ductal, Breast
Investigators on the most trials with Dr. Mansueti
- Ellen L. Ziaja, MD5 shared trials
- Robert Blair Ash, MD4 shared trials
- Hani Lamei Ashamalla, MD4 shared trials
Recent clinical trials with Dr. Mansueti
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial (opens in a new tab)
Active, not recruitingPhase 2
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicDocetaxelErlotinib HydrochlorideGemcitabine
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients with Stage IIa-IIIa Breast Cancer (opens in a new tab)
Active, not recruitingPhase 3
Carcinoma, LobularCarcinoma, Ductal, BreastHypofractionated Radiation TherapyRadiation Therapy
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer (opens in a new tab)
Active, not recruitingPhase 3
Intensity-Modulated Radiation TherapyStereotactic Body Radiation Therapy
Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer (opens in a new tab)
Active, not recruitingPhase 2/3
Intensity-Modulated Radiation TherapyThree-Dimensional Conformal Radiation Therapy
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. John Romeo Mansueti received $14,489 in industry payments from 2016 to 2025
CMS Open Payments shows 339 general payments to Dr. Mansueti from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,692.
General payments to Dr. Mansueti by program year, 2016 to 2025
General payments to Dr. Mansueti by kind, 2016 to 2025
$14.5Kin total
- Food and beverage$13,66994%
- Travel and lodging$8206%
Companies that paid Dr. Mansueti the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. John Romeo Mansueti graduated from Uniformed Services UHS Fe Hebert School of Med
Dr. Mansueti graduated from Uniformed Services UHS Fe Hebert School of Med in 1999.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. John Romeo Mansueti's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. John Romeo Mansueti
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. John Romeo Mansueti's NPI number?
Dr. John Romeo Mansueti's NPI number is 1699776955. It was assigned on August 9, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. John Romeo Mansueti?
Dr. John Romeo Mansueti is a radiation oncologist in Seaford, Delaware. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. John Romeo Mansueti practice?
Dr. Mansueti practices at 801 Middleford Rd, Seaford, DE 19973. Dr. Mansueti's primary practice is TidalHealth Nanticoke in Seaford, Delaware, part of TidalHealth Peninsula Regional. Dmand AI also links Dr. Mansueti to 2 hospitals, 1 group practice or clinic and 1 therapy and rehab clinic.
What is Dr. John Romeo Mansueti's office phone number?
The practice phone on file for Dr. Mansueti is (302) 629-6611.
What is Dr. John Romeo Mansueti's medical license number?
Dr. Mansueti holds Virginia license 0101228433.
Which hospitals is Dr. John Romeo Mansueti affiliated with?
Dr. Mansueti practices at TidalHealth Nanticoke in Seaford, Delaware. Dr. Mansueti is also affiliated with TidalHealth Peninsula Regional. Dmand AI links Dr. Mansueti to 2 more hospitals.
What medical group is Dr. John Romeo Mansueti part of?
Dr. Mansueti is linked to Associates in Radiation Medicine.
Does Dr. John Romeo Mansueti accept Medicare?
Yes. CMS data shows Dr. Mansueti billed Medicare for 6,192 services in 2024, and Dr. Mansueti accepts Medicare assignment.
What is Dr. John Romeo Mansueti's MIPS score?
Dr. Mansueti's MIPS final score for performance year 2024 is 0 out of 100, reported individually.
How many Medicare patients does Dr. John Romeo Mansueti see?
CMS counts 456 Medicare patients who saw Dr. Mansueti in 2024, with an average age of 74.
Show 6 more questionsShow fewer questions
What services does Dr. John Romeo Mansueti bill to Medicare?
In 2024, Dr. Mansueti's most billed Medicare services were radiation oncology (77014), medicare service (G6015) and radiation oncology (77427).
Where did Dr. John Romeo Mansueti go to medical school?
Dr. Mansueti graduated from Uniformed Services UHS Fe Hebert School of Med in 1999.
What drugs does Dr. John Romeo Mansueti prescribe most?
In 2024 Medicare Part D data, Dr. Mansueti's most prescribed drugs by claims were Tamsulosin HCl, Oxycodone HCl and Tramadol HCl.
Has Dr. John Romeo Mansueti received payments from drug or device companies?
CMS Open Payments shows $14,489 in general payments to Dr. Mansueti from 66 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. John Romeo Mansueti been practicing?
Dr. Mansueti graduated from medical school in 1999, 27 years ago.
Does Dr. John Romeo Mansueti do research?
Dr. Mansueti has worked on 6 clinical trials.
Selling to radiation oncology practices?
See radiation oncologists in Delaware by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card